These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21304129)

  • 1. Worsening mania associated with slow increase of quetiapine dose.
    Cordoba S; de Asis J; Kotbi N; Mahgoub N
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E5-6. PubMed ID: 21304129
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose quetiapine induced or worsened mania in the context of possible undertreatment.
    Millard HY; Wilson BA; Noordsy DL
    J Am Board Fam Med; 2015; 28(1):154-8. PubMed ID: 25567837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine may induce mania: a case report.
    Biancosino B; Marmai L; Facchi A; Rossi E; Grassi L
    Can J Psychiatry; 2003 Jun; 48(5):349-50. PubMed ID: 12866345
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mania induced by quetiapine in patients with schizoaffective disorder, depressive type: a case report].
    Nicolato R; Ferreira Rde A; Fonseca EV; Fonseca SG; Amaral Tda S
    Braz J Psychiatry; 2009 Sep; 31(3):286-7. PubMed ID: 19784499
    [No Abstract]   [Full Text] [Related]  

  • 5. Manic symptoms associated with quetiapine treatment.
    Lykouras L; Oulis P; Hatzimanolis J
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):135-6. PubMed ID: 12650959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine-associated and dose-related hypomania in a woman with schizophrenia.
    Atmaca M; Kuloglu M; Buyukbayram A; Tezcan E
    Eur Psychiatry; 2002 Sep; 17(5):292-3. PubMed ID: 12381500
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid quetiapine loading in youths with bipolar disorder.
    Scheffer RE; Tripathi A; Kirkpatrick FG; Schultz T
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):441-5. PubMed ID: 20973715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
    Michopoulos I; Ferentinos P; Oulis P; Gournellis R
    J Clin Psychopharmacol; 2014 Feb; 34(1):159-61. PubMed ID: 24135842
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
    Ketter TA; Brooks JO; Hoblyn JC; Holland AA; Nam JY; Culver JL; Marsh WK; Bonner JC
    J Psychiatr Res; 2010 Oct; 44(14):921-9. PubMed ID: 20378127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
    Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
    Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine-induced mania.
    Pacchiarotti I; Manfredi G; Kotzalidis GD; Girardi P; Tatarelli R
    Aust N Z J Psychiatry; 2003 Oct; 37(5):626. PubMed ID: 14511093
    [No Abstract]   [Full Text] [Related]  

  • 13. The emergence of darkness phobia in a bipolar patient during quetiapine treatment.
    Teresa Plana M; Mane A; Benabarre A; Goikolea JM; Vieta E
    J Clin Psychiatry; 2006 Apr; 67(4):673-4. PubMed ID: 16669734
    [No Abstract]   [Full Text] [Related]  

  • 14. Cabergoline associated with first episode mania.
    Harris YT; Harris AZ; Deasis JM; Ferrando SJ; Reddy N; Young RC
    Psychosomatics; 2012; 53(6):595-600. PubMed ID: 22658326
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF; Paulsson B; Brecher M
    J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
    Riesenberg RA; Baldytcheva I; Datto C
    Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression.
    Suppes T; Datto C; Minkwitz M; Nordenhem A; Walker C; Darko D
    J Affect Disord; 2010 Feb; 121(1-2):106-15. PubMed ID: 19903574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mania associated with quetiapine treatment].
    Cam B; Gülseren S
    Turk Psikiyatri Derg; 2014; 25(1):65-8. PubMed ID: 24590852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.